Rezaei Mitra, Karimi Galougahi Mahboobeh, Kheradmand Azin, Pourabdollah Toutkaboni Mihan, Mir Mohammad Sadeghi Hassan, Abdollahi Alireza, Emami Razavi Amirnader, Safavi Naini Ali, Bidari-Zerehpoosh Farahnaz
Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iran J Pathol. 2021 Winter;16(1):20-26. doi: 10.30699/ijp.2020.119344.2300. Epub 2020 Oct 10.
BACKGROUND & OBJECTIVE: Human papillomavirus (HPV) has been associated with prognosis in patients with head and neck squamous cell carcinoma (HNSCC). Similar to the global studies, different prevalence rates of this viral infection have been reported in Iran. Therefore, we aimed to report the prevalence of this virus and its significance in HNSCC patients.
Patients who were referred to the five hospitals of Tehran city from May 2018 to May 2019 were enrolled in this study. All patients were diagnosed with HNSCC based on pathologic study. The pathologic disease staging was defined, and DNAs were extracted from the fresh tissue samples via kits. After polymerase chain reaction (PCR), HPV positive samples were evaluated for determining genotypes and data analysis.
Of the 46 patients, three patients (6.5%) showed positive HPV results with the following subtypes: 18 (in two patients), 52 (in three patients), 61 (in two patients), 67, and 73.Comparison of variables between the groups with and without HPV showed a significant difference based on the tumor's lymphatic invasion (=0.041), peripheral lymph node involvement (=0.008), and histologic grade (=0.011), but no statistically significant difference in terms of other variables such as age, primary tumor site, size, pathologic stage, vascular or perineural invasion, metastasis, smoking, and alcohol consumption was found.
人乳头瘤病毒(HPV)与头颈部鳞状细胞癌(HNSCC)患者的预后相关。与全球研究类似,伊朗报道了这种病毒感染的不同患病率。因此,我们旨在报告该病毒在HNSCC患者中的患病率及其意义。
本研究纳入了2018年5月至2019年5月转诊至德黑兰市五家医院的患者。所有患者均根据病理研究确诊为HNSCC。定义病理疾病分期,并通过试剂盒从新鲜组织样本中提取DNA。经过聚合酶链反应(PCR)后,对HPV阳性样本进行评估以确定基因型并进行数据分析。
46例患者中,3例(6.5%)HPV检测结果呈阳性,其亚型如下:18型(2例)、52型(3例)、61型(2例)、67型和73型。HPV阳性组与阴性组之间的变量比较显示,基于肿瘤的淋巴浸润(P=0.041)、外周淋巴结受累(P=0.008)和组织学分级(P=0.011)存在显著差异,但在年龄、原发肿瘤部位、大小、病理分期、血管或神经周围浸润、转移、吸烟和饮酒等其他变量方面未发现统计学显著差异。